ArticleFrontiers in genetics2026
An auxiliary diagnosis model for the pathological classification of cervical cancer based on radiomics biomarkers.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cervical cancer remains a major global health burden, and accurate pathological classification is essential for personalized treatment planning. However, conventional radiomics studies often rely on manual lesion delineation and are limited in extracting meaningful imaging biomarkers from heterogeneous cervical cancer lesions. Methods: We proposed a convolutional recurrent feature extraction (CRFE)-based automatic segmentation framework for cervical cancer MRI images and developed histogram-based imaging features reflecting lesion pixel concentration trends. These features were integrated with conventional radiomics and clinical features. Feature engineering and machine learning classifiers, including random forest (RF), XGBoost, support vector machine, and logistic regression, were evaluated to construct an auxiliary diagnostic model for pathological classification. The dataset included 114 patients with cervical cancer who underwent MRI examinations. Results: The CRFE segmentation model achieved an Intersection over Union (IoU) of 0.9443, a Dice coefficient of 0.5980, and an F1-score of 0.7085. Feature selection retained 30 key imaging biomarkers, including the median of the histogram, GLSZM large-area low gray-level emphasis (LoG, Discussion: The proposed deep learning-radiomics framework enables accurate lesion segmentation and effective pathological classification of cervical cancer. This auxiliary diagnostic model may reduce unnecessary invasive procedures and improve early screening and clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.